ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020
Consensus Recommendations on the Use of
Open access · bronzeAbstract readConsensus Statement
In one paragraph
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 16 citations in OpenAlex.
- Pulmonary [European journal of nuclear medicine and molecular imaging · 2026Article
- Assessment of the Diagnostic Value of [Diagnostics (Basel, Switzerland) · 2025Article
- [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Imaging technologies in experimental pulmonary fibrosis research: essential tool for enhanced translational relevance.European respiratory review : an official journal of the European Respiratory Society · 2025Review
- Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meeting.BMC medicine · 2025Article
- [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- Lung functional imaging.Breathe (Sheffield, England) · 2023Article
- 2-deoxy-2-[Molecular imaging and biology · 2023Article
- Overview of positron emission tomography in functional imaging of the lungs for diffuse lung diseases.The British journal of radiology · 2022Review
- Reply: Measurement of hypoxia in the lung in idiopathic pulmonary fibrosis: a matter of control.The European respiratory journal · 2022Article
- Quantitative FDG PET Assessment for Oncology Therapy.Cancers · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
34 authors at 17 institutions in 4 countries.
Delphine L ChenDepartment of Radiology, University of Washington, Seattle Cancer Care Alliance, Seattle, Washington dlchen7@uw.edu.
Safia BalloutSchool of Physics and Astronomy, University of Leeds, Leeds, United Kingdom.
Laigao ChenWorldwide Research, Development, and Medical, Pfizer Inc., Cambridge, Massachusetts dlchen7@uw.edu.
Joseph CheriyanCambridge University Hospitals, NHS Foundation Trust, Cambridge, United Kingdom.
Gourab ChoudhuryEdinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Ana M Denis-BacelarNational Physical Laboratory, Teddington, United Kingdom.
Elise EmondInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Kjell ErlandssonInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Marie FiskDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Francesco FraioliInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Ashley M GrovesInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Roger N GunninviCRO, London, United Kingdom.
Jun HatazawaDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University, Osaka, Japan.
Beverley F HolmanNuclear Medicine Department, Royal Free Hospital, London, United Kingdom.
Brian F HuttonInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Hidehiro IidaFaculty of Biomedicine and Turku PET Center, University of Turku, Turku, Finland.
Sarah LeeAmallis Consulting Ltd., London, United Kingdom.
William MacNeeEdinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Keiko MatsunagaDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University, Osaka, Japan.
Divya MohanMedical Innovation, Value Evidence, and Outcomes, GlaxoSmithKline R&D, Collegeville, Pennsylvania.
David ParrUniversity Hospitals Coventry and Warwickshire, Coventry, United Kingdom.
Alaleh RashidnasabInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Gaia RizzoinviCRO, London, United Kingdom.
Deepak SubramanianDerby Teaching Hospitals, NHS Foundation Trust, Derby, United Kingdom.
Ruth Tal-SingerMedical Innovation, Value Evidence, and Outcomes, GlaxoSmithKline R&D, Collegeville, Pennsylvania.
Kris ThielemansInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Nicola TregayDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Edwin J R van BeekEdinburgh Imaging, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Laurence VassDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Marcos F Vidal MeloDepartment of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Jeremy W WellenResearch and Early Development, Celgene, Cambridge, Massachusetts; and.
Ian WilkinsonCambridge University Hospitals, NHS Foundation Trust, Cambridge, United Kingdom.
Frederick J WilsonClinical Imaging, Clinical Pharmacology, and Experimental Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
Tilo WinklerDepartment of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
University College London · GBUniversity of Cambridge · GBCambridge University Hospitals NHS Foundation Trust · GBGlaxoSmithKline (United States) · USImperial College London · GBOsaka University · JPThe Queen's Medical Research Institute · GBGlaxoSmithKline (United Kingdom) · GBHarvard University · USMassachusetts General Hospital · USNational Physical Laboratory · GBPfizer (United States) · USUniversity Hospitals Coventry and Warwickshire NHS Trust · GBUniversity of Edinburgh · GBUniversity of Leeds · GBUniversity of Turku · FIUniversity of Washington · US
Funding
Training/DisseminationP41EB025815 · NIBIB · WASHINGTON UNIVERSITY · PI Buck E. Rogers · 2018 to 2026
$12.7MRegional Tidal Lung Strain and Neutrophilic Inflammation in Early Lung InjuryR01HL121228 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI VIDAL MELO, MARCOS F · 2014 to 2023
$6.2MPOSITRON EMISSION TOMOGRAPHIC IMAGING OF LUNG TRANSPLANTR01HL121218 · NHLBI · WASHINGTON UNIVERSITY · PI CHEN, DELPHINE L, GELMAN, ANDREW ERIC · 2014 to 2017
$2.8MPET IMAGING CCR2 IN LUNG INFLAMMATIONR01HL131908 · NHLBI · WASHINGTON UNIVERSITY · PI BRODY, STEVEN, LIU, YONGJIAN · 2016 to 2018
$2.0MMedical Research Council G0701127NHLBI NIH HHS R01 HL121218NHLBI NIH HHS R01 HL121228NHLBI NIH HHS R01 HL131908NIBIB NIH HHS P41 EB025815
Abstract
PET with
Indexed as
Fluorodeoxyglucose F18Practice Guidelines as TopicHumansImage Processing, Computer-AssistedInjectionsLung DiseasesPatient PositioningPositron Emission Tomography Computed TomographyRespirationFluorodeoxyglucose F18FDGlung diseasePET/CTpulmonary imaging
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.